Targeted Brain Tumor Radiotherapy Using an Auger Emitter.

Giacomo Pirovano1, Stephen A Jannetti1,2,3, Lukas M Carter1

  • 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

Summary

A novel radiotherapeutic, Iodine-123 Meitner-Auger PARP1 inhibitor (123I-MAPi), shows promise for treating glioblastoma. This targeted therapy effectively damages cancer cells and prolongs survival in preclinical models.

Related Concept Videos